Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study.
about
What can imaging tell us about cognitive impairment and dementia?Biomarkers in dementia: clinical utility and new directionsThe advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Magnetic resonance elastography of frontotemporal dementia.The impact of neurodegeneration on network connectivity: a study of change detection in frontotemporal dementia.Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions.Data-driven regions of interest for longitudinal change in frontotemporal lobar degeneration.Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration.Improving response inhibition systems in frontotemporal dementia with citalopram.Biomarkers in frontotemporal lobar degenerations--progress and challenges.Performance on the Frontal Assessment Battery is sensitive to frontal lobe damage in stroke patients.Predicting functional decline in behavioural variant frontotemporal dementia.Longitudinal diffusion tensor imaging in frontotemporal dementia.Magnetoencephalography of frontotemporal dementia: spatiotemporally localized changes during semantic decisions.Quantitating severity and progression in primary progressive aphasia.Advances in neuroimaging in frontotemporal dementia.Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degenerationDifferential longitudinal decline on the Mini-Mental State Examination in frontotemporal lobar degeneration and Alzheimer disease.MTA index: a simple 2D-method for assessing atrophy of the medial temporal lobe using clinically available neuroimaging.Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD).Semantic dementia: a specific network-opathy.EFNS task force: the use of neuroimaging in the diagnosis of dementia.Neuroimaging of rapidly progressive dementias, part 1: neurodegenerative etiologies.From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkers.Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.Clinical staging of semantic dementia in an FDG-PET study using FTLD-CDR.Apples are not the only fruit: the effects of concept typicality on semantic representation in the anterior temporal lobe.Quantifying change in individual subjects affected by frontotemporal lobar degeneration using automated longitudinal MRI volumetry.The clinical spectrum of sporadic and familial forms of frontotemporal dementia.The frontal assessment battery in clinical practice: a systematic review.Retrospective Diagnosis of Parkinsonian Syndromes Using Whole-Brain Atrophy Rates.Disease modification and Neuroprotection in neurodegenerative disorders.Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin.Biomarkers in frontotemporal dementia
P2860
Q26749292-BED8100D-0039-4F77-9183-792EDACFC15FQ27007086-46C537CF-0DFA-4478-8B04-797F3A663B8FQ28485924-5252A23E-E2EA-4026-AEB4-2466991AFC80Q30390206-A81F425B-0F47-4B0E-86E4-764A723F5094Q30452411-570C534E-C306-4F67-8BFC-45F9E68DBCC4Q30570437-F0611528-D1B6-4CF0-8F66-0FB2D9155EB2Q31122791-83742CE7-0D1F-4E56-B6A8-91427B37E86AQ33562216-FA1C5C66-0210-4460-AB99-DB33ACB9BCB1Q33625542-E59C74FF-3D7B-40A3-A172-2EF501EAAFF2Q33893515-D7DAAE43-4333-46CA-A87F-7D831B04F24AQ34478445-EA402A64-CFBF-4B3C-B0D2-8A7E29E30545Q34538903-E9FB9E90-9041-4108-827E-F6AAAE2FD61CQ35008632-96F24F6A-3711-42B8-88FE-0A95762B99A0Q35206966-20D958AF-0A8C-4278-8D0C-29738899C59CQ35523051-C78040EB-0756-4E35-80A3-6D10F0B1001CQ36097857-296EF26A-0648-4454-981D-4E6643E97DE1Q36165159-93A27F3D-7E43-461A-897E-48D6E0A4D364Q36828462-481831D5-D5B4-4E13-89CC-10CF4C91116DQ37672946-E8E45AB3-C060-439B-93EC-3E585FEB4F88Q37678074-5A45ACF6-D49F-4146-98A1-6A84393DA962Q37895186-054CFCD7-A97C-484A-B08B-62FF4ED4FF62Q38035398-63337FBC-531B-4BA2-93FE-94EE7CA4BBEEQ38084188-2AF14A42-A072-4E8D-AF06-407CDA6FF076Q38101089-C40F584E-1E6C-4D0C-BB29-B5B0836CB96CQ38391397-8C37EE7B-88CB-40E4-907F-C883AFF7D445Q38460271-F025232D-1D24-4524-8909-CF067CD18945Q38472776-217CDAB8-EF26-4F79-A55D-73AF5351FE73Q38490454-29EF03CE-2EFB-45E0-A716-C844AE5C1539Q38825197-8BE9EB1E-CD3D-4A8C-90F3-9D6EC6FF7B75Q39382484-942FAEA7-E813-4BD5-BBB9-0880E5D084A7Q42291087-E706BD1F-1E83-4EB6-BB08-22EE05C90C19Q42363882-F822AB92-9AFE-4CE1-9E39-1F17BD7B743BQ47819962-5C4D090E-410D-456E-9445-74F593A0601DQ57911950-2E65D0E3-4746-4F6D-AF02-C2D84B13B9DB
P2860
Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Measuring disease progression ...... ion: a clinical and MRI study.
@ast
Measuring disease progression ...... ion: a clinical and MRI study.
@en
type
label
Measuring disease progression ...... ion: a clinical and MRI study.
@ast
Measuring disease progression ...... ion: a clinical and MRI study.
@en
prefLabel
Measuring disease progression ...... ion: a clinical and MRI study.
@ast
Measuring disease progression ...... ion: a clinical and MRI study.
@en
P2860
P50
P1433
P1476
Measuring disease progression ...... tion: a clinical and MRI study
@en
P2860
P304
P356
10.1212/WNL.0B013E3181D1A879
P407
P577
2010-02-01T00:00:00Z